Nuclear therapy and molecular imaging are widely used at hospitals for new promising medical procedures. They can drastically improve the outcome for many medical conditions and in particular enable the treatment of disseminated ...
Sep 24, 2021
0
11
After several decades of pre-clinical development, cell- and gene-based therapies for Parkinson's disease (PD) are now actively being explored. In this special supplement to the Journal of Parkinson's Disease, "Repairing ...
Sep 24, 2021
0
21
Smoking among young teens has become an increasingly challenging and costly public healthcare issue. Despite legislation to prevent the marketing of tobacco products to children, tobacco companies have shrewdly adapted their ...
Jul 12, 2021
0
2
Pioneering research into how our bodies manufacture the cells that make blood has moved us closer to regrowing tissues and organs. The findings also may let doctors grow cells for transplantation into people to battle cancer, ...
Jan 27, 2021
0
5
With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use to alleviate symptoms of many illnesses including Parkinson's disease (PD). According to results of a survey of PD patients ...
Jan 26, 2021
0
23
Medicinal cannabis could offer patients significant relief from intractable epilepsy, but cost and access barriers remain, a review has found.
Dec 18, 2020
0
0
According to a Rutgers-led national survey, most doctors misperceive the risks of nicotine, the addictive chemical in tobacco products.
Sep 10, 2020
0
2
Up to now, adult men with non-metastatic castration-resistant prostate cancer (nmCRPC) at high risk of developing metastatic disease usually continued their conventional androgen deprivation therapy (ADT) while the cancer ...
Aug 3, 2020
0
4
The combination of ceftolozane with tazobactam broadens the range of antibiotic therapy in adults with severe infections of the lungs, the urinary tract, the renal pelvis and the abdominal cavity. In view of the increasing ...
Jul 2, 2020
0
1
Since its approval in April 2019, dacomitinib has been available for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor ...
Aug 19, 2019
0
3
